Logo image of INMB

INMUNE BIO INC (INMB) Stock Analyst Ratings

NASDAQ:INMB - Nasdaq - US45782T1051 - Common Stock - Currency: USD

2.42  +0.18 (+8.04%)

Premarket: 2.46 +0.04 (+1.65%)

Buy % Consensus

78

ChartMill assigns a Buy % Consensus number of 78% to INMB. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 11.66. This target is 381.9% above the current price.
INMB was analyzed by 11 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about INMB.
In the last month the buy percentage fell by 6 points. So the trust of analysts is decreasing.
INMB was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.
INMB Historical Analyst RatingsINMB Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -75 -68 -61 -54 -47 -40 -33 -26 -19 -12 -5 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 2.420.617.6511.6626.25 - -74.96% 216.12% 381.90% 984.71%
INMB Current Analyst RatingINMB Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4
Up and Down Grades
Date Firm Action Rating
2025-07-02 Maxim Group Maintains Buy -> Buy
2025-07-01 ScotiaBank Downgrade Sector Outperform -> Sector Underperform
2025-07-01 BTIG Downgrade Buy -> Neutral
2025-02-13 Maxim Group Maintains Buy -> Buy
2025-02-11 ScotiaBank Maintains Sector Outperform -> Sector Outperform
2024-10-21 Alliance Global Partners Initiate Buy
2024-09-27 Raymond James Initiate Outperform
2024-08-22 ScotiaBank Initiate Sector Outperform
2023-06-01 Baird Initiate Outperform
2022-05-24 BTIG Maintains Buy
2022-05-24 B. Riley Securities Downgrade Buy -> Neutral
2022-01-24 B. Riley Securities Maintains Buy
2021-04-21 B. Riley FBR Initiate Buy